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Despite significant progress in the field of tissue engineering within the last 
decade, a number of unsolved problems still remain. One of the most relevant issues 
is the lack of proper vascularization that limits the size of engineered tissues to 
smaller than clinically relevant dimensions. In particular, the growth of engineered 
tissue in vitro within bioreactors is plagued with this challenge. Specifically, the 
tubular perfusion system bioreactor has been used for large scale bone constructs; 
however these engineered constructs lack inherent vasculature and quickly develop a 
hypoxic core, where no nutrient exchange can occur, thus leading to cell death. 
Through the use of 3D printed vascular templates in conjunction with a tubular 
perfusion system bioreactor, we attempt to create an endothelial cell monolayer on 
3D scaffolds that could potentially serve as the foundation of inherent vasculature 
within these engineered bone grafts.   
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Chapter 1: Introduction  
Clinicians and researchers are investigating novel methods for repairing 
critically sized bone defects to meet the large demand for bone repair in the clinic. 
Currently, bone is second only to blood as the most transplanted tissue.1 Bone tissue 
defects can be due to elevated levels of stress associated with physical activity, obesity, 
and aging.  Approximately 15 million bone fractures occurred worldwide in 2011, with 
nearly 10% resulting in nonunions.1 A nonunion fracture is classified as a fracture 
which fails to heal after nine months without intervention (Figure 1).2  
  
Figure 1. Nonunion versus malunion fracture.  
Nonunion fractures take an extended or indefinite time to heal, while typical 
fractures heal within a few weeks.3 Commonly, these nonunions result in a significant 
displacement between the two fractured ends; if this displacement is large enough as to 
not allow for natural healing, the gap is then classified as being above the critical 
defect size. Normally, bone fractures with gaps below the critical defect size will fill 




etc) of the fracture. These critically sized defects require larger scale bone grafts and 
thus there is a large clinical need to develop one grafts on this larger scale.   
In 2010, the CDC reported 342,030 hospitalizations in the United States for 
extremity fractures with an average treatment cost of about $34,016.4 Conservatively, 
about 10% of traumatic fractures result in a nonunion.5 In these cases, surgical 
intervention is commonly needed to fully heal the wound through the use of artificial 
supports and bone grafts. The goal of bone grafts and bone tissue engineering strategies 
is to create a living tissue that can self-maintain and grow within a patient. Nonunions 
that require surgery to aid the closure of the critically sized gap can be complicated by 
infection and rejection of the implant, thus potentially leading to multiple revision 
surgeries and further complications.3 Therefore, it is critical to optimize these surgical 
treatment strategies in order to reduce the potential physical and economic effects of 
complications.   
Approximately 1 million grafting procedures are performed each year.6 
Transplanted human tissue used for bone regeneration is derived from either 
autologous sources (elsewhere in the patient’s body) or from donated allogeneic tissue 
(e.g. cadaveric tissue, living donors). Currently, the gold standard for harvesting bone 
tissue for implantation are autografts because autologous tissues have immune 
reaction side effects and complications.2,7 Unfortunately however, both options have 
significant disadvantages and the rate of complications arising from an allograft is 
nearly 30%.8 Furthermore, the introduction of a secondary defect site increases the 




donation site.5 Additionally, there are limitations as to which patients may receive 
autografts and the maximum donation size is limited. Elderly, young, and sick may 
not be able to donate their own bone tissue for reimplantation, and up to 20% of 
patients experience complications from the harvesting procedure.7   
Cadaveric donors overcome one limitation of autologous transplants- 
constrained supply- by providing allogeneic bone structures capable of bearing load 
without the restrictions of donor site morbidity. While allografts are the most widely 
available option for treating long bone defects, fresh allografts are rarely used due to the 
potential of serious infections such as HIV and Hepatitis C and the presence of 
immunogenic factors.7 Therefore, allogeneic bone requires processing prior to 
transplantation, which also decreases the desirable biological activity of the tissue.7 Still 
the greater quantity of bone tissue available to surgeons allows them to pack allografts 
at higher density and promote osteoconduction.2   
Substitute materials can be engineered with highly reproducible and tunable 
properties, which makes it a desirable potential substitute for bone tissue engineering 
constructs. Researchers are currently investigating in vitro strategies in an attempt to 
develop an alternative that can overcome the complications that arise as a result of the 
current clinical practices. Generally, the tissue engineering approach involves seeding 
and growing a cell source on a scaffold and implanting it into the injury site.8 While 
strides have been made in the field of bone tissue engineering research, a major limitation 
of such 3D constructs is that they have been optimized for a single cell population to 




transfer. In order to increase the feasibility of cell based tissue engineering strategies, this 
limitation must be overcome.   
The most common component of engineered vascular constructs is the presence 
of endothelial cells. Many techniques are currently being investigated for the 
development of vascularized networks with the ultimate goal of developing inherent 
vasculature within engineered bone tissue grafts. Some of these methods include of in 
vitro or in vivo prevascularization of grafts; however due to several disadvantages of 
these methods, more recent research has focused on 3D printing of vascular scaffolds.  
Bone constructs are typically grown in small modules in bioreactor systems to 
maintain nutrient transfer in vitro. A bioreactor is a cell culture system that is used to 
support or expand a population of cells through dynamic conditions within a 
controlled environment.8 An important benefit of bioreactor systems is their ability to 
create an in vitro environment that mimics the in vivo environment of the human body 
more closely. They do so by providing mechanical stresses and increased nutrient 
transport via flow. The tubular growth chamber design is more commonly used for the 
tissue engineering of vascular grafts, where vascular tissue growth is directed either 
around the outside of a 3D scaffold or around the inner walls of a growth chamber.9  
The research presented here focuses on the development of an endothelial 
monolayer that would serve as the foundation for the development of inherent vasculature 
within these engineered bone tissue grafts. Through the combination of a tubular 




examine the effects of architecture and shear stress on the formation of endothelial cell 
monolayer formation.   




Chapter 2: Related Literature   
Introduction  
Vascular networks are an essential element of any biological system, providing 
cells with oxygen and glucose, while also removing waste products.10,11,12 Because of 
their role in nutrient and waste exchange, they are also the limiting factor within the 
human body – cells are restricted to a maximum distance of 100-200 μm from the 
nearest capillary.10,11 Despite the overwhelming presence of vascular networks within 
the body, vascularization of implantable bone grafts remains a major limitation, 
especially in engineering large scale bone grafts.   
  While inherent vasculature in engineered bone tissue grafts has yet to be 
successful on a larger clinically relevant scale, the human body has demonstrated the 
ability for vascular tissues to spontaneously invade implanted tissue.10,13 However, 
host vasculature invades from the outside of the implanted scaffold inwards; 
therefore, the time required to achieve sufficient vascularization depends on the 
thickness of the implant. This spontaneous vascular ingrowth has been measured to 
occur on the order of a few hundred nanometers per day, thus requiring several weeks 
to fully vascularize even smaller scale constructs.13 During this time, implantable 
constructs rapidly develop a necrotic core10,12,14,15; the cells that do not die experience 
a nutrient gradient in which the cells on the outermost aspect of the construct consume 




oxygen concentrations decrease toward the center of the scaffold, and eventually drop 
below the minimum necessary to sustain cell growth.13  
The need to develop inherent vasculature within engineered bone tissue grafts 
is apparent, and many different vascularization techniques are currently being 
developed and tested. It is important to note however, that while there are many 
different cell culture and tissue engineering strategies used throughout research, many 
vascularization techniques are incompatible with certain tissue engineering strategies. 
Because of this disconnect, it is essential to determine which cell culture and construct 
formation strategy will work best for the intended application when designing 
vasculature for bone tissue engineering.   
  Classical tissue engineering methods generally involve fabrication of scaffolds 
made of either natural or synthetic materials, and cells of interest are then seeded onto 
them. Recently, focus has shifted towards the additive layer-by-layer robotic 
fabrication of 3D scaffolds used in tissue engineering. This technology provides 
advantages over classical tissue engineering such as higher precision and resolution of 
printed geometries.16 Majority of these techniques are based on the use of computer-
aided design (CAD) information, which is then converted into a series of cross 
sectional layers.  
Bioreactors have been shown to improve cell seeding efficiency and cell 
proliferation.8 Clinically, one of the most notable benefits of a bioreactor system in the 
field of tissue engineering is the potential for automation; significant benefits of 




decreasing the risk of contamination, labor, and costs normally associated with in vitro 
cell culture.8  
The research presented here focuses primarily on the use of tubular perfusion 
system (TPS) bioreactors, and the vascularization techniques were therefore tuned for use 
within this bioreactor system.  
TPS Bioreactors  
Bioreactor Design  
Tissue engineering research is increasingly relying on the use of advanced cell 
culture technologies that provide rigorously controlled cell microenvironments. There 
are a variety of bioreactors currently being utilized in the field of bone tissue 
engineering; generally, the three main classes of bioreactors include spinner flasks, 
rotating wall systems, and perfusion systems, each having their own specific advantages 
and disadvantages. While there are many different systems, the common goal of all of 
these bioreactors is to provide controlled mechanical stimuli as well as regulate cell 
culture media.17 Mechanical stimuli through flow of media over the scaffolds provides 
shear stress, while regulation of cell culture media provides sufficient levels of nutrient 
and waste exchange to all cells in a uniform manner.   
 Physiologically relevant shear stresses for endothelial cells can be as high as 70 
dyne/ cm2.18 Therefore, many tissue engineering bioreactor systems seek to expose 
human umbilical vein endothelial cells to these levels of shear stress, in an attempt to 




  While all of the previously mentioned methods of dynamic culture have 
shown benefits over traditional static culture, success has been modest in spinner flask 
and rotating wall bioreactors, due to the less-ordered nature of the systems.17 In its 
most basic form, as spinner flask bioreactor simply consists of a bone tissue 
engineering (BTE) scaffold submerged in a flask containing cell culture media. 
Mechanical stimuli and flow of media is then provided via convection created by the 
spinning of a stir bar at the base of the beaker. Similarly, a rotating wall bioreactor 
contains a BTE scaffold in a flask consisting of two concentric cylinders. Here, the 
flow of media is driven through the viscous effects of media in contact with the both 
the stationary inner wall, and the rotating outer wall. In both of these systems, 
convection of media is relegated to the periphery of the constructs, and, while 
advantageous as compared to static culture, they still require small-scale constructs to 
allow for full diffusion of the necessary nutrients to the core of these constructs.17 In 
fact, cell death is often observed in the core of scaffolds as close as 200 µm from the 
scaffold surface.19  
  Perfusion bioreactors overcome many of the limitations of spinner flask and 
rotating wall bioreactors, but require a significantly more complex setup. A typical 
perfusion bioreactor is composed of a media flask, which feeds into a custom-fit reaction 
chamber, via a tubing circuit. The media is then perfused through a scaffold construct 
through the use of a pump. These systems have demonstrated increased proliferation and 
viability of endothelial cells as compared to static culture and other dynamic culture 




scaffolds and not around it, the scaffold must be press fit into a custom sized reaction 
chamber to eliminate any void space between the scaffold and the chamber walls. To 
overcome these limitations, a system is needed that can provide for increased perfusion 
of nutrients and increased shear stresses, while eliminating of the need for custom fit 
reaction chambers.  
Advantages of a TPS Bioreactor   
Tubular perfusion system (TPS) bioreactors overcome all of these limitations 
through a unique design. The TPS bioreactor has several important advantages over 
other existing bioreactor systems. Many perfusion bioreactor systems are composed of 
customized components that require custom manufacture. The TPS bioreactor, 
however, is made entirely of off-the-shelf components, making the system easy and 
cheap to manufacture and modify.9 It can accommodate large and small scaffold sizes 
and multiple scaffolds simultaneously through the adjustment of the growth chamber 
and medium reservoir size. Furthermore, the TPS bioreactor is easily reproducible, 
allowing for experimental standardization and consistency, which is important for 
clinical use.9 The medium flow rate in this system may be accurately adjusted between 
2 and 240 mL/min. This large flow rate range allows for thorough experimentation of 
the effect of flow rate and thus shear stress on cell proliferation and differentiation. 
The bioreactor system can easily and efficiently be sterilized via autoclaving, which 




Tissue Engineering Strategies for Vascularized Constructs   
  All living cells require nutrients for sustained growth and viability. In the 
body, diffusion of oxygen is limited to only 100-200 µm from the nearest 
capillary.10,11,13 Without functional vascular networks being integrated into 3D 
engineered tissues, the cells very quickly become necrotic. Despite recent 
advancements in bone tissue engineering, this diffusion requirement has been a 
limiting factor, resulting in clinically used implants to be thin or avascular tissues, 
which can only be vascularized by spontaneous host-capillary invasion.13 To address 
the need for larger-scale tissue constructs, several vascularization techniques are 
currently under investigation, both in vitro and in vivo.   
  The most common component of engineered vascular constructs is the  
presence of endothelial cells.20,21,22,23 Endothelial cells are the foundation of native 
vasculature; they form a confluent monolayer which lines vascular networks, thus 
providing an effective barrier to prevent hemorrhage while also allowing for nutrient 
exchange. Mammalian cells require a constant oxygen supply and waste disposal 
mechanisms in order to survive. They are located within 100-200 um of blood vessels, 
which is the diffusion limit for oxygen. Briefly, vascular networks are formed via a 
three-phase process. First, endothelial progenitor cells (EPCs) differentiate and 
proliferate to form the early stages of a capillary network. In this phase known as is 
vasculogenesis, the primary capillary network is formed. The next phase is 
angiogenesis, which refers to the formation of new capillary vessels from pre-existing 




(MMPs), which serve to degrade the extracellular matrices (ECMs) surrounding the 
primitive networks formed during vasculogenesis. As the ECM degrades, proliferating 
endothelial cells migrate into the void, remodeling and elongating the network to form 
blood vessels. Finally, these blood vessels are remodeled and  
enlarged into larger vessels and arteries in a process called arteriogenesis.13  
 For thin constructs, there is no significant need for a vascular network formation 
prior to implantation. Hypoxic conditions within constructs trigger the release of 
angiogenic growth factors. In combination with the host inflammatory response, 
these angiogenic growth factors trigger spontaneous host-capillary invasion that 
provides sufficient vascularization for thin grafts.13 Current vascularization strategies 
are being used in conjunction with this natural response in an attempt to provide 
sufficiently perfused larger scale vascularized constructs.  
  One such technique, termed in vivo prevascularization, provides implants with 
a vascular network that spans the major axis of a construct. The advantages of this 
technique are that it allows for direct microsurgical anastomosis of the construct to the 
host vasculature, thus resulting in immediate perfusion of the construct. However, this 
technique requires a host to undergo two separate surgeries. The BTE construct is 
initially implanted into a healthy region of the body with a major artery. Over a span 
of several weeks, the graft and the axial vasculature of the artery merge, and once the 
vascular axis within the graft is sufficient, it is removed from the implant growth site 
and inserted into the defect site.13 While this technique overcomes many of the major 




surgeries, as well as the removal of a major vascular axis from the initial implant site 
are significant drawbacks. In particular, the requirement for an axial vascular network 
to be removed from the initial implant site once again places limitations on the size of 
the implant –as construct size increases, the removal of the initial implant becomes 
more dangerous.  
  Another approach utilizes in vitro prevascularization. Under the right 
conditions, EPCs can be directed to differentiate into endothelial cells and form 
vascular networks. Several design strategies include the addition of growth factors such 
as vascular endothelial growth factor (VEGF), basic fibroblast growth factor  
(bFGF), platelet-derived growth factor (PDGF), and transforming growth factor β  
(TGF- β), among others, to stimulate the formation and remodeling of vascular 
networks. However, adding too much of a growth factor can result in negative 
consequences, which includes hemorrhagic vessels, and undesirable differentiation of 
seeded cells.13 While these strategies result in spontaneous, random 
microvascularization of constructs, they are not sufficient as standalone techniques for 
the complete vascularization of large scale constructs. Therefore, in vitro and in vivo 
prevascularization techniques are often combined with other scaffold-based 
techniques.  
3D Printing of Bone and Vascular Tissue Constructs   
  To combat many of the issues of the methods mentioned above, 3D printing is often 
utilized. Here, there are two primary ways in which 3D printing techniques are used to 




utilizing printing techniques that create user-defined vascular channels and surface 
topography. The second method, which is also the method most commonly used, is 
sacrificial molding. Several methods of 3D printing are used to create scaffolds with user-
defined geometries and topographical structures. These techniques largely serve the same 
purpose, with the major differences being the types of materials that can be used with each 
technique, and the resolution that each method offers. 3D printing can simply be broken 
down into two primary techniques: stereolithography and extrusion based printing.   
Stereolithography involves the use of a liquid polymer resin and a light source. 
Here, the light source can either be visible light, or ultraviolet (UV) light, depending 
on the polymer. This technique requires that the polymer have side chains, such as 
methacrylate groups, which crosslink when exposed to a beam of light. Here, highly 
focused light causes crosslinking of the photopolymer in a layer-by-layer fashion. 
Some of the main limiting factors of the stereolithographic approach include cell 
death caused by UV light, the requirement that polymers be photo-crosslinkable, and 
scaffold thickness limitations based on the max depth of light penetration.15 Despite 
these limitations, important advantages of stereolithography include relatively quick 
and hands-off production, good resolution, and a high degree of reproducibility.24  
  Extrusion based printing, which includes techniques such as fused deposition 
modeling (FDM) and fused filament fabrication (FFF), involves the layer-by-layer addition of 
material. Extrusion occurs either by drawing the material through a nozzle (FFF), or by 
applying pressure to force the material through a nozzle (FDM). Under an FDM system, the 




multiple material types. Here, the polymer is placed at a temperature that allows for extrusion, 
while keeping it viscous enough to maintain strand integrity. By tuning the applied pressure 
and print head movement speed, strand diameter can be carefully controlled, and polymer 
fibers are deposited layer by layer onto a build plate. Under this system, UV crosslinkable 
photopolymers can also be used by simply curing each layer with UV light before the next 
layer is applied. While it is a highly reproducible printing method, this technique is limited by 
a relatively large resolution, which is driven by the minimum strand diameter, a function of 
the print nozzle diameter. Further, this technique is limited by the strength of attachment of 
each layer to the next, as well as the imperfect alignment of each rounded strand to the 
rounded strand in the previous layer.  
For these reasons, sacrificial molding is the more commonly utilized technique 
for designing and creating vasculature in BTE constructs. Sacrificial molding involves 
the creation of a user-defined vascular mold. These molds can either be formed by 
printing a mold within a hydrogel to be filled with a sacrificial material, or by forming 
the scaffold around the sacrificial template. Major limitations of sacrificial molding 
include cytotoxicity of sacrificial materials14, and the challenges associated with 
creating relevantly sized, interconnected vascular channels.  
Another common method of creating sacrificial networks is solvent cast 
molding. Here, a soluble material such as poly(vinyl alcohol) (PVA), is poured into a 
mold of the desired shape.14 The cast is then allowed to solidify, and the tissue 
construct is built up around it. Once the construct is complete, the cast is sacrificed by 




Alternatively, certain cast materials can be sacrificed at elevated temperatures. These 
methods are limited by the properties of the sacrificial material, as they must be durable 
enough to withstand the process of generating the construct, while at the same be easily 
sacrificed under conditions that are not harmful to the construct or the cells 
encapsulated within them.   
  Another way to create sacrificial channels within BTE constructs is through 
the incorporation of electrospun fibers. Electrospinning is the process of nanofiber 
formation driven by an electric current applied to a fluid jet composed of a polymer 
dissolved in a solvent.25 Electrospinning, commonly combined with a 
polydimethylsiloxane (PDMS) scaffold, allows for the formation of a complex 
nanochannel network. 25 Electrospun fiber materials can then be sacrificed in a variety 
of  
ways, such as the dissolution polyethylene oxide and pullulan fibers in water. 25, 26  
 Despite the vast array of different vascularization strategies currently under 
investigation, relevantly sized BTE constructs remain largely avascular. Furthermore, the 
majority of the vascularization techniques produce vasculature on the micro-scale. 
However, the diameter of the human femoral artery ranges from about 6 mm to about  
10 mm, highlighting the clinical need to develop inherent vasculature on a much larger scale.27 
Therefore, a significant need exists to identify strategies that will allow for the vascularization of 





Oxygen in the HUVEC Niche   
  In vivo oxygen concentrations are known to influence cellular respiration, 
proliferation, and viability. Recent studies have examined the influence of oxygen 
concentration on HUVEC viability and proliferation.   
  Atmospheric air consists of 20.95% O2, or roughly 160 mm Hg.28 By the time 
inhaled oxygen reaches arterial blood, these levels decrease to about 7-12%, and drop 
further to less than 5% in venous and capillary blood.29,30 Further, interstitial oxygen 
levels within human tissues and organs range from around 2-9%28,29, while average 
oxygen tensions within healthy bone marrow range from 6-7% 29,30,31. Cells within 
BTE constructs under dynamic culture have been shown to live for up to seven days at 
oxygen levels just below 4%, whereas identical constructs under static culture yielded 
0% central oxygen concentrations in only five days, and marked cell death.32 
Additionally, long term exposure to oxygen tensions below 1% result in massive 
levels of cell death.33   
Effect of Architecture and Topographic Patterns on Endothelial Cell Behavior  
  Recent developments in micro- and nanofabrication techniques have enabled the 
fabrication of substrates that are able to mimic the structure and length scale of native 
topography in two-dimensional and three-dimensional substrates.34 Cells respond to 
synthetic topographic substrates in a wide array of responses, which depend upon many 
factors including cell type, feature size and geometry. Three basic nanotopographic 




nanopost arrays, and nanopit arrays. Nanotopography affects basic cell function in 
almost all types of mammalian cells.  
It is well known that human tissues, including bone and vasculature, exist in 
the form of naturally well-organized nanoscale topographies for tissue specific 
function.35 Furthermore, it has been accepted that topography can strongly influence 
the morphology and orientation of living cells through a phenomenon known as 
contact guidance and through integrin mediated intracellular tension, which may play 
an essential role in determining characteristic functions of complex tissues.35 The 
interaction of mammalian cells with nanoscale topography has proven to be an 
important signaling modality in controlling cell function – naturally occurring 
nanotopographic structures within the extracellular matrix present surrounding cells 
with mechanotransductive cues that influence local migration, cell polarization, and 
other functions.34 Furthermore, it has been accepted that topography can strongly 
influence the morphology and orientation of living cells, through contact guidance as 
well. Contact guidance is a leading example of a naturally occurring phenomenon that 
is characterized by the response of cells to structures on the micron and sub-micron 
scale.34,35 Synthetically nanofabricated topography can also influence cell morphology, 
alignment, adhesion, migration, proliferation, and cytoskeleton organization.34   
Perhaps the most palpable effect of nanotopography on cell function is the impact 
upon cell geometry. Many cell types, including endothelial cells, typically respond to 
nanogratings by simultaneously aligning and elongating in the direction of the grating 




Studies have demonstrated that some nanograting feature sizes induced 
alignment of cells both parallel and orthogonally to the nanograting axis.36,37 Recent 
studies have also shown that in static conditions that human umbilical vein endothelial 
cells (HUVECs) were highly aligned on anisotropically nanopatterned scaffolds with 
nanogrooves, which contrasts their observed random morphology and orientation on 
flat surfaces.35 Furthermore, it has been shown that HUVECs elongate more strongly 
on sparser nanogrooved density scaffolds than on relatively denser ones.35 These 
results indicate that nanopatterned matrices strongly influence the alignment and 
orientation of HUVECs, which also coincides with the natural orientation of these 
cells in vivo.35 Nanopit features have been shown to elicit a more subtle effect on 
cellular morphology, and studies of both nanoposts and nanopits, illustrated a 
decrease spread of cells, although the overall effect of these structures on cell area is 
unclear.35  
Capillary formation of endothelial cells is another important behavior because it 
is the initial process for formation of new blood vessels. Pioneering research by 
Bettinger et al. demonstrated that nanotopography had an ability to promoted natural 
capillary formation of endothelial progenitor cells.37  
Nantopography has also been shown to influence attachment and adhesion of 
cells. Nanogratings generally appear to enhance the adhesion in various cellbiomaterial-
geometry combinations. The effect of nanotopography on migration is typically 




have exhibited biased migration direction in the direction of the grating axis and 
increased overall migration velocities.36  
Additionally, surface topography has also been shown to alter gene expression 
in endothelial cells. In a co-culture system of HUVECs and human mesenchymal stem 
cells (hMSCs) seeded on a nanopattern surface, increased Connexin 43 expression 
compared to the flat surface was seen, indicating that the nanopattern surface may 
provide an environment more suitable for cell-cell communication, most likely due to 
the controlled cell shapes.35   
It is important that synthesized vascular grafts need to be capable of 
maintaining the appropriate phenotype of endothelial cells in vitro. Phenotypic 
maintenance of endothelial cells are typically evaluated by the expression of 
endothelial markers such as platelet endothelial cell adhesion molecular 1 (PECAM1), 
vascular endothelial cadherin (VE-cadherin), vascular cell adhesion molecule-1 
(VCAM-1), and intercellular adhesion molecule-1 (ICAM-1). PECAM-1 plays a role 
in controlling adhesion between endothelial cells and leukocytes or to adjacent 
endothelial cells. VE-cadherin mediates intercellular junctions which assist in 
maintaining the integrity of the endothelial layer. VCAM-1 and ICAM-1 are up 
regulated during inflammation. Studies have demonstrated that nanotopography has 
the ability to maintain phenotypes of endothelial cells. Endothelial cells on aligned 
nanofiber meshes showed an aligned morphology in parallel with nanofibers and 
expression of three endothelial markers listed above, which represented phenotypic 




Although studies have provided important insights into topography as an 
enabling tool for advanced stem cell-based vascular tissue engineering, further progress 
is required for the recapitulation of the natural topography observed in the native 
vascular environment.35 Even with the existing advanced micro- and nanofabrication 
techniques, it is difficult to prepare highly ordered nanoscale features over a large 
area.37   
  Effects of Shear Stress on Endothelial Cell Behavior     
  Fluidic shear stress is a crucial factor for vascular cell function including 
proliferation, elongation, and protein secretion. The shear stress applied to the surface 
of the inner vessel wall ranges from 10 to 70 dyn/ cm2 (arteries), or 1 to 6 dyn/ cm2 
(veins).37 The use of perfusion of medium through an entire cell-seeded scaffolds, 
enables efficient and uniform mass transfer of oxygen and other soluble factors 
throughout the entire scaffold, in a similar manner to the role of vasculature in 
tissues.18 In addition to its role in mass transfer, the perfusing media produces a 
frictional force on the surface of the cells known as shear stress. Exposure to high shear 
stress on the order of 10-70 dyne cm2 is normal for vascular endothelial cells, as they 
make up the inner layer of the arterial vascular network.18 Because fluid shear stress is 
an important regulator of cell behavior, many studies have attempted to study its 
effects on cultivated cells, specifically endothelial cells.   
One such study seeded HUVECs in alginate scaffolds at three different levels 




different levels of the membrane marker Intercellular Adhesion Molecule 1 (ICAM-1) 
as well as phosphorylated endothelial nitric oxide synthetase (eNOS).18 Additionally, 
Tsuboi et.al. showed that in 2D HUVEC culture, increasing shear stress in the range of 
0 to 20 dyne cm2 caused increasing levels of ICAM-1 expression in a shear dependent 
manner as well.18 Sun et.al. showed that nitric oxide (NO) levels increased when 
mesenteric arterioles were subjected to shear stresses ranging from 1 to 15 dyne cm2.18 
NO is synthesized by eNOS which is activated by its phosphorylation, and therefore 
there is strong correlation between NO levels and p-eNOS levels in cells. Together, 
these results indicate that mechanical shear stress via flow rate influences HUVEC 
gene expression.   
Shear stress has been also shown to induce cell sprouting in HUVEC cultures, in 
a shear stress-dependent manner. Kang et. al subjected HUVECs to a laminar shear 
stress ranging from 0.12- 12 dyne cm2 which illustrated that the invasion distance of 
HUVEC sprouts into a 3D collagen matrix increased in a shear stress dependent 
manner18.      
Chapter 3: The Effect of Architecture and Shear Stress on 
Endothelialization of 3D Printed Vascular Networks  
Introduction  
With nearly 15 million bone fractures1 and 1 million bone grafting procedures 
worldwide6 each year, there is a large clinical need for relevantly sized tissue 
engineered alternatives. Conventional techniques have so far been limited to tissue 




vasculature for long term graft functionality. While inherent vasculature in larger 
scale, clinically relevant sized engineered bone tissue grafts has yet to be successful, 
the human body has demonstrated the ability for vascular tissues to spontaneously 
invade implanted tissue.10,13 However, host vasculature invades from the outside of the 
implanted scaffold inwards; therefore, these larger scaffolds rapidly develop a necrotic 
core.10,12,14,15   
  Classical tissue engineering methods generally involve fabrication of scaffolds 
made of either natural or synthetic materials and cells of interest are seeded onto 
them. Recently, focus has shifted towards the additive layer-by-layer robotic 
fabrication of 3D scaffolds used in tissue engineering. This technology provides 
advantages over classical tissue engineering such as higher precision and resolution of 
printed geometries.16 Nanotopography, including nanochannels, nanopillars, and 
nanopits have been used to enhance cell proliferation and migration of endothelial  
cells.   
Bioreactors have been shown to improve cell seeding efficiency and cell 
proliferation.8 Clinically, one of the most notable benefits of a bioreactor system in the 
field of tissue engineering is the potential for automation; significant benefits of 
automated cell culture in a continuously closed system include dramatically 
decreasing risk of contamination, labor, and costs normally associated with in vitro 
cell culture.8   
The research presented here focuses on the use of a TPS bioreactor and 3D 




combination, to study the effect of architecture and shear stress on endothelial cell 
monolayer formation.  In our study we hypothesize that our micron scale channels and 
novel channels and pits combination surface topography will alter surface shear stress 
in a manner that will enhance proliferation and monolayer formation.   
Materials and Methods   
SolidWorks Geometry Generation  
  The use of stereolithography and other 3D printing techniques are 
advantageous not only because of the high degree of accuracy that they produce, but 
also because they allow any lab to reproduce the results of another, as long as they 
have access to the same computer-aided design (CAD) files. However, the CAD files 
must first be developed. Here, SolidWorks was utilized to create all structures to be 
printed. First, concept drawings were created that began and ended with a single inlet 
and outlet, respectively. The overall length of the scaffolds designed was limited by the 
length of the printer build platform, or approximately 70 mm. Once all of the design 
parameters were known, the actual CAD model could be developed, as seen in Figures 
2-4.   
SolidWorks Flow Simulations   
Bioreactor studies using three-dimensional scaffolds, provide information 
about shear stress effects, but additional variables in the system can make it difficult to 
calculate exact shear stresses cells are exposed to. Complex modeling is required to 




threedimensional scaffolds with varying surface topography, and these shears are 
influenced by factors that are difficult to measure including cell growth and 
extracellular matrix deposition. Additional benefits of running these flow simulations 
are that you are able to perform a large amount of them in a short amount of time and 
obtain a large amount of information from each simulation. This allows quick 
optimization of study designs.   
Computational fluid dynamics (CFD) analyses was run utilizing the  
SolidWorks “Flow Simulation” add-in. SolidWorks develops accurate flow profiles by 
solving the Navier-Stokes equations for conservation of energy, mass, and 
momentum, using a finite volume analysis. A unique feature of CFD in SolidWorks is 
that it automatically determines the fluid volume, making it easy to set up. Further, 
because CAD models were originally designed in SolidWorks, there was no need to 
convert files or create entirely new files. However, SolidWorks CFD does require that 
all fluid volumes be fully constrained, so that the software can determine flow paths.  
Boundary conditions were then imposed, assuming fully developed flow. For 
each experimental group, flow simulations were performed at 0.5, 1, 2, 5, 10 and 20 
mL/min, which was imposed at the inlet boundary, and an environmental pressure (1 
atm) was imposed as the outlet boundary condition. Finally, flow of media was 
modeled as water and blood at 37 ºC, gravity was imposed to account for the vertical 
orientation of the reaction chamber within the incubator, and mesh resolution was set 
to “4”. This resolution value was determined to give the best results within a 




assumptions are made by this modeling technique – it assumes 37 ºC, fully developed 
flow at the inlet, finite volume, and boundary conditions for both fluid volume rate and 
environmental pressure.   
Experimental Group Determination   
For the bioreactor study which utilized 3D printed scaffolds, the experimental 
groups were based on cylindrical diameter and surface topography. Cylinders were 
divided into Groups 1-3, each with a different inner diameters, 4.5mm, 10 mm, and 16 
mm, respectively (Figures 2-4). Scaffold diameters were chosen so that the scaffolds 
would fit flush within the tubing sizes available for use in the bioreactor, ensuring that 
all media flow went through, not around the scaffolds. The length of the cylinder in 
each group was calculated so that the cylinders in each group would have the same 
total inner surface area. Static control samples, one corresponding to each dynamic 
experimental group were used as controls. This group altogether are referred to as 
“Static Control” in all relevant graphs and tables. All other groups were cultured in a 
TPS bioreactor.  
  
  
Figure 2: Group 1 diameter dimensions. a. Inner and outer diameters (mm). b.  




Length of cylinder (mm).  
           
Figure 3: Group 2 diameter dimensions. a. Inner and outer diameters (mm). b.  
Length of cylinder (mm).  
                
Figure 4: Group 3 diameter dimensions. a. Inner and outer diameters (mm). b.  
Length of cylinder (mm).   
  
Additionally, within each group, three different surface topographies were 
analyzed – no pattern flat surface, channels, and channels & pits (Figure 5). The 
channels seen in Figure 5 were 0.400 mm in height, and 0.400 mm in width. 0.400 mm 
spacing was also used between each channel. The pits in Figure 5b were 0.800 mm in 
depth and 0.400 mm wide. They were also spaced 0.400 mm from each other.   
a  b  




             
Figure 5: a. Channel surface topography. b. Channel and pits combination 
surface topography.    
  
Initially, smaller topographical features were designed and created to more 
closely mimic the nanotopography of the in vivo vascular environment; however, these 
designs failed to successfully print due to the resolution of the 3D printer, so the 
channels and pits topography was scaled up to the dimensions shown in Figure 5.   
For studies under static conditions as well as dynamic growth chamber studies 
under flow, 2D printed scaffolds were used. Experimental groups were divided based on 
surface topography: no pattern flat surface, channels, and channels & pits.  
3D Printing  
All 3D printing was completed using a Digital Light Processing (DLP) 
stereolithography printer (EnvisionTec). A clear polymer, EShell 300 (EnvisionTec) 
was chosen for both the perfusion network, and the connectors. EShell 300 is a clear, 
photo-crosslinkable polymer, due to the functionalization of both acrylate and 
methacrylate groups. Tuned by the manufacturer for use with EnvisionTec DLP 




printers, it provides resolutions on the order of 100-150µm, and is designed as a 
bioinert polymer for commercial hearing aid manufacturing. This material was chosen 
for several reasons: it is well characterized by the company (EnvisionTec), cheap, and 
easy to obtain.  
First, CAD files of networks and connectors were imported as .stl files to 
Magics, an STL editor software. Parts were rotated and translated as necessary to align 
them to the build plate. They were then “fixed” using the built-in features of  
Magics to correct overlapping geometries, holes, etc. From here, support structures were 
generated within Magics. Support structures attach to the print files, and allow for rounded 
structures to adhere to the build platform, and ensure that the construct did not collapse during the 
build process. Part files and support structures were then imported to Perfactory RP 
(EnvisionTec), a software which allows the user to translate .stl files to the proper format to be 
used with Perfactory printers. Here, parts can be angled and rotated to allow for optimal use of 
build platform space.  
Additionally, build style is selected here. The EnvisionTec default build style for EShell 
300 was used, with a step size of 50 µm. The Perfactory 4 (EnvisionTec) was the DLP 
printer utilized for all prints. Ensuring that the projector light type was set to  
“UV,” the intensity was calibrated to 180 mW/dm2, as is recommended by the 
manufacturer. A 48-field calibration was used to achieve the highest degree of 
accuracy. Once calibrated, the flat calibration plate was exchanged in favor of the 
material tray, which features silicone rubber walls to allow for the containment of the 




was left to run its course. Build times for job files ranged from 2-7 hours.   Once the 
printer finished, the build platform was raised and prints were removed from the build 
platform using a putty knife. At this point, prints were soft-cured, meaning that they 
maintained their shape, but were still very soft and sticky to the touch due to the 
presence of partially cured polymer. Prints were cleaned by spraying them gently with 
99% isopropanol, and then placed into an isopropanol bath on a shaker platform for 
approximately 15 minutes. This cleaning process served to remove excess polymer, 
and ensure that pits and channels were not occluded.   
Following the cleaning process, parts were dried with compressed air, and 
support structures were trimmed using a razor blade and an X-ACTO knife. Parts were 
washed and dried again, and cured through the application of 1500 flashes in a light 
polymerization chamber (EnvisionTec). Remaining support structure debris was then 
sanded down to yield smooth surfaces. Constructs with and without support structures 
can be seen in Figure 6.   
  
Figure 6: Example of EShell 300 Clear Print a. Side view with supports. b. Top 
view with supports.   




EShell Sterilization   
  Because EShell parts cannot be autoclaved, the 3D printed scaffolds were 
sterilized by a sterilization-rehydration protocol. First, five sterile beakers were sprayed 
with 70% ethanol and transported to a sterile hood. Similarly, an unopened 1 gallon jug 
of 100% ethanol was sprayed into the hood, along with sterile phosphatebuffered saline 
(PBS, pH 7.4). The five beakers were filled with five different solutions (one each), of 
100% PBS, 25%-75% ethanol-PBS, 50%-50% ethanol-PBS,  
75%-25% ethanol-PBS, and 100% ethanol. All parts to be sterilized were submerged in 100% 
ethanol and exposed to UV light for 15 minutes. Then, parts were gradually rehydrated in PBS by 
soaking them in increasing percentages of PBS, for five minutes per beaker, all while exposed to 
UV. Once the parts reached the final, 100%  
PBS, solution, they were removed using sterile tweezers and stored submerged in PBS 
in sterile 50 mL Falcon tubes.  
Cell Culture   
  Human umbilical vein endothelial cells (HUVEC) (Lonza Inc., Walkersville, 
USA) were purchased and cultured according to standard protocols.16 Plated cells 
were kept at 37 °C in a 5% CO2 atmosphere. Endothelial basal media (EBM-2) 
(Lonza Inc.) combined with the EMB-2 bullet kit (Lonza Inc) was used to make media 
changes to cell culture plates every two days as well as one day prior to 
experimentation in order to ensure 100% confluency and high cell yield. All cells used 
in the study were passage 3 or 4. HUVECs were chosen as the cell line to use in these 




Fibronectin Coating and Cell Seeding   
Prior to cell seeding, samples were coated overnight with 3 ug/uL fibronectin 
concentration in 50 mL Falcon conical tubes on a rotator, which allowed for a more 
even distribution of the fibronectin on the scaffolds. Fibronectin coating was used to 
enhance cell adhesion rates on the EShell scaffolds. Experiments were done using a 
cell seeding concentration of 5000 cells/ cm2. Following fibronecting coating, scaffolds 
were seeded overnight in 37°C incubator before studies were begun.   
Static 2D Setup  
Static studies were performed with 2D disc shaped constructs with no pattern 
flat surfaces. The prints were placed in a petri dish and submerged with media until 
assessed at various time points; the setup can be seen in Figure 7 with the media 
represented as the pink fluid and the print as the gray flat disc.  Three time points were 
assessed using live dead stain on days 1, 3, and 7.   
  
Figure 7. Static 2D setup in a petri dish.   
Dynamic Growth Chamber Setup   
  Since microscopic imaging on 3D constructs is challenging, we used 2D  
EShell 300 clear circular prints under the same shear stress to perform viability and 
morphological analysis. Prints had varying surface topography – no pattern flat 




representation of the inner surface of the 3D scaffolds in the TPS bioreactor 
experiments. The setup as shown in Figure 8, uses a syringe pump (Harvard 
Apparatus) that held a 10mL syringe loaded with media. This allowed for controlled 
flow rate of media into the growth chamber apparatus at 0.005 mL/min. The shear 
stress on the print could be controlled by choosing one of the three gaskets available 
for this growth chamber model labeled A, B, and C. The gaskets vary in thickness and 
flow path widths. The gasket that was chosen for this study was gasket A, which has a 
thickness of 0.005 inches and a flow path width of 0.25 cm; our reason for this 
selection is that gasket A allowed us to reach the shear rate that we wanted, which was 
5 dyn/ cm2, while also reducing the number of times the syringe had to be reloaded 
with media by using a lower flow rate to obtain the shear stress we wanted. The 
growth chamber was attached to a vacuum line, which was important for keeping the 
seal tight around the cell culture area on the print.  
These studies were performed for a 24 hour period, at which time the samples were 
analyzed for attachment efficiency, orientation, morphology and viability.  
  
  





Bioreactor Setup  
A Masterflex L/S peristaltic pump (Cole-Parmer) drives the flow of media throughout 
the bioreactor. Masterflex two stop L/S 14 tubing is fed into the pump.  
Tubing is connected using silver ion-lined microbial resistant tubing connectors (Cole  
Parmer) of varying sizes. The platinum cured silicone tubing was chosen for its low  
chemical leachability, minimal protein binding, and high gas permeability to allow for 
easy exchange of carbon dioxide and oxygen.   
All tubing and connectors were first autoclaved, with the exception of EShell 
parts, which were sterilized as described above. Using appropriate 1/8-1/8” 
connectors, 1/8” ID tubing extends from both ends of the pump tubing, and one end is 
fed into the media flask, which is stopped with a rubber stopper with two holes for 
tubing. Each line on the bioreactor featured tubing sizes ranging from 1/8” to 3/4”, 
which allowed the cylinders were varying diameters from all groups to be run on the 
same line simultaneously. In each tubing segment, shown as green in Figure 9, two 
scaffolds would be present. Connectors, shown in pink in Figure 9, were used to 
connect segments to one another and prevent any potential leaking. The final 
combination of connectors and the perfusion network resulted in a system that allowed 





Figure 9: Model of bioreactor setup showing one complete tubing line circuit.  
Green represents tubing containing scaffolds. Pink represents connectors 






Figure 10: Bioreactor setup with lines in parallel.  
The bioreactor setup was designed in a way that all experimental groups could be 
tested simultaneously, under the same flow conditions. All bioreactor groups were run in 
parallel on the same pump (Figure 10).  Once set up in a sterile hood, the entire system 
is then transported to a cell culture incubator at 37 ºC, with 5% CO2. Each tubing line 
had its own separate media flask, filled with 250 mL of perfusion media as demonstrated 
by Figure 10, which features the complete setup installed into the incubator at 37 ºC. 
The medium is withdrawn and replaced from the reservoir through two tubes that 




culture hood, removing the medium in the reservoir and replacing it with a fresh 
medium. This provides for a change of 80% of medium. All groups were exposed to a 
flow rate of 20 mL/min.  
Viability, Morphology & Proliferation Analysis   
Cell viability was assessed using a live dead assay following standard protocols 
as described previously.9 Samples were incubated in 2 uM ethidium homodimers and 4 
uM calcein AM (Molecular Probes) for 30 minutes. Fluorescent images were then 
taken using a fluorescent microscope (Axiovert 40 CFL with filter set 23; Zeiss, 
Thornwood, NY) equipped with a digital camera (Diagnostic  
Instruments 11.2 Color Mosaic, Sterling Heights, MI).    
For the analysis of growth chamber and static samples, viability, attachment 
efficiency, morphology and proliferation of HUVECs were assessed. Attachment 
efficiency was assessed on Day 1 (24 hr) using five images, one from each quadrant as 
well as one image from the center of the construct. Images were taken on Days 1 
(24h), Day 3 and Day 7 for morphology analysis, which included aspect ratio and 
orientation of cells. Proliferation was assessed on Day 7.   
For the calculation of the aspect ratio, twenty or more fluorescent images were 
taken at 20x. Aspect ratio is normally calculated as width divided by height (Figure 
11). However, in our study, orientation in static conditions was irrelevant, so we could 
simplify our calculation to dividing the longer side, side 1, by the shorter side, side 2 




tool.   
  
Figure 11: Aspect ratio calculated by dividing width by height.  
  
Figure 12: Aspect ratio calculated by dividing longest side by shorter side, as 
done in this study.  
  
Attachment efficiency in the table below was calculated by dividing the total cells 
counted on Day 1 (24h) by the original number of cells seeded on the print, and then 
multiplying by 100 to get the attachment efficiency value in a percentage.      
For bioreactor samples, proliferation, morphology and viability were assessed 
on Day 7. A static sample for each experimental group served as the negative controls.   
All microscopic images analysis was performed using the ImageJ software. 




all images were processed uniformly to prevent misrepresentation of data. Images were 
first processed, and then live dead images were merged.   
Cell counts were obtained from individual live or dead images at 2.5x, 10x and 
20x magnification. The images were counted using the cell counter feature on ImageJ.   
DNA Analysis   
  DNA was extracted at the Day 7 time point for the bioreactor study samples 
using the following procedure previously described in the literature.9 Isolated cell pellets 
were resuspended in 200 uL of PBS isolated using a DNeasy Tissue Kit  
(Qiagen, Valencia, CA) following standard protocols to produce 400 uL of eluate. 
Double stranded DNA was then quantified by mixing 50 uL of DNA eluate with 50 uL 
of diluted Quanti-iT Pico Green dsDNA reagent (Molecular Probes, Carlsbad,  
CA), incubating for 5 min in the dark and measuring fluorescence using an M5 
SpectraMax plate reader (Molecular Devices, Sunnyvale, CA) with excitation/emission 
of 480/520 nm. All samples were performed in triplicate (n=3).  
Statistical Analysis   
  For statistical analysis in the static conditions and dynamic growth chamber 
studies, a two sample T Test was used with a 95% confidence level. For statistical analysis 




Results   
SolidWorks CFD Analysis   
The purpose of the SolidWorks flow simulations is to determine what flow rate 
to use in bioreactor study to obtain physiologically relevant shear stress. CFD results 
from SolidWorks flow simulations demonstrate flow velocity profiles and shear 
stresses similar to average velocities in previous TPS bioreactor experiments.9 
Furthermore, flow profiles for all experimental groups examined varied by diameter 
and topography.  Surface plot contours of shear stress (Figure 13), flow trajectories of 
the flow velocities (Figure 14) and surface shear stress results (Tables 1-3) were 
obtained for each sample under each flow rate simulation. More images of these flow 
simulations can be found in Appendix B. Looking at Figure 14, it is important to note 
that the effect of surface topography on shear stress profiles can be seen – the pits 
pattern at the flow rate shown has a lower shear stress than the surrounding scaffold 
area. Thus, even prior to starting the bioreactor study, we were able to see the 
influence of surface architecture eon the shear stress profile sensed by endothelial 






Figure 13: Surface plot contour of shear stress, group 2 diameter with channels 
and pits, flow rate of 10 mL/minute.  
  
Figure 14: Flow trajectory of group 2 diameter with channels and pits, flow rate 


































(dyn/ cm2)   
Group 1 
diameter  
(4.5 mm)  
  
0.5  
No pattern  
/flat 
surface  
0.00837  0.04849  0.01712  
1  0.10581  0.46391  0.19925  
2  0.19041  0.76888  0.34971  
5  0.40017  1.78646  0.73020  
10  0.70159  3.3068  1.27418  




0.00050  0.19241  0.01329  
1  0.00100  0.35354  0.02658  
2  0.00220  0.61852  0.05283  
5  0.00220  0.61852  0.05283  
10  0.01243  2.28568  0.21712  




0  0.05294  0.00591  
1  5.385E-07  0.03077  0.00279  
2  0  0.02543  0.00263  
5  0  0.06239  0.00714  
10  0  0.12492  0.01426  
20  0  0.29339  0.02950  
Table 1: Surface shear stress results for group 1 diameter experimental groups 


























(dyn/ cm2)   
Group 2  
Diameter  




No pattern  
/flat 
surface  
0.00035  0.00076  0.000549  
1  
0.00076  0.00149  0.001103  
2  
0.00155  0.00295  0.002209  
5  
0.00400  0.00713  0.005533  
10  
0.00839  0.01387  0.01108  
20  




5.56E-08  0.01117  9.85E-05  
1  
9.30E-08  0.02058  0.00020  
2  
9.27E-08  0.03804  0.00041  
5  
1.40E-07  0.08591  0.00107  
10  
1.14E-06  0.15947  0.00222  
20  




4.70E-09  0.00347  7.36E-05  
1  
0  0.00616  0.00015  
2  
0  0.01126  0.00032  
5  
0  0.02702  0.00088  
10  
0  0.05184  0.00183  
20  
0  0.09878  0.00378  
Table 2: Surface shear stress results from group 2 diameter experimental groups 








Group  Flow Rate 






(dyn/ cm2)  
Maximum  
shear stress  




(dyn/ cm2)   
Group 3 
diameter 




No pattern  
/flat  
surface  
4.09E-05  0.00021  0.00012  
1  0.00011  0.00040  0.00025  
2  0.00027  0.00078  0.00051  
5  0.00069  0.00192  0.00127  
10  0.00143  0.00376  0.00255  




0  0.00045  3.45E-05  
1  0  0.00094  7.26E-05  
2  0  0.00094  7.26E-05  
5  0  0.00393  0.00038  
10  4.60E-07  0.00771  0.00080  
20  0  0.01497  0.00162  






Pits  0  0.00073  5.09E-05  
2  0  0.00143  0.00011  
5  6.75E-08  0.00351  0.00027  
10  2.36E-08  0.00693  0.00058  
20  0  0.01351  0.00122  
Table 3: Surface shear stress results from group 3 diameter experimental groups 
in bioreactor study.  
The surface shear stress results in Tables 1-3 were used to determine which flow 
rate to use in the TPS bioreactor study since we wanted to use as close to a 
physiologically relevant shear stress as possible, while also not using such a high flow 
rate that the flow could potentially shear off the fibronectin coating. In all Tables 1-3, as 
the flow rate increased in every experimental group from 0.5 mL/minute to 20 mL/min, 
the average shear stress increased as well. Using the conclusions we made from these 
surface shear stress results, we decided to use 20 mL/minute flow rate because it had 
the widest range between the minimum and maximum shear stress in each group, which 
would allow us to see the largest variation of shear stress in a single bioreactor study. 
Additionally, out of all the flow rates simulated, 20 mL/min produced shear stresses 
closest to the physiologically relevant range, and thus was chosen as the flow rate to use 
in our TPS bioreactor study.   
Focusing in on the 20 mL/minute flow rate shear stress results we saw that in the 




stress average of 2.23 dynes/cm2, which decreased in the channels topography group to 
0.37 dyne/cm2 and even further in the channels and pits topography group to 0.29 
dyne/cm2. Thus, the general trend seen here is that with increasing surface 
topographical complexity there is a decrease in the average shear stress values. This 
same trend was seen in the medium sized (Figure 16) and largest sized (Figure 17) 
diameter groups as well.   
  
Figure 15. Group 1 diameter shear stress results for each experimental group at 





Figure 16. Group 2 diameter shear stress results for each experimental group at 





Figure 17. Group 3 diameter shear stress results for each experimental group at 
20 mL/minute flow rate.   
  
  
Static Conditions Endothelial Cell Analysis  
  The purpose of the static 2D studies was to assess endothelial cell behavior in 
static conditions in order to serve as comparative baseline values for the dynamic 
studies. Live/dead images were taken on Day 1, 3, and 7 of the no pattern flat surface 
2D prints in the static conditions study. Cells at the day 1 time point were consistently 
more rounded (Figure 18), with an aspect ratio closer to 1 (1.75 +/- 0.5), while cells on 
day 3 (Figure 19) were much more elongated with an aspect ratio much greater than 1 
(8.3 +/- 3.7). Using the aspect ratio calculation method previously described, we 
calculated average aspect ratios on Day 1 and Day 3 for static conditions samples, as 
shown in Figure 20.  The aspect ratio is notably larger in the day 3 samples, and when 
using a 95% confidence interval on a 2 sample T-test, the difference was statistically 
significant (p < 0.05). Thus, as time increased the aspect ratio of the HUVECs 





Figure 18: Selected images of HUVEC on day 1 at 20x. Live dead stain, green: 
calcein stain for live cells.   
  
Figure 19: Selected images of HUVEC on day 3 at 20x. Live dead stain, green: 
calcein stain for live cells.  
  
  
Figure 20: Aspect ratio of HUVEC on day 1 versus day 3. * indicates p < 0.05.   
  
HUVEC attachment efficiency was also calculated on day 1 using live/dead 




efficiency was calculated to be 23% +/- 6 (n=5 samples). Additionally, although 
endothelial cell binding to fibronectin as a substrate is well established, coating of 
EShell polymer with fibronect in order to provide proper endothelial cell attachment has 
not previously been demonstrated. The data presented here illustrates that fibronectin 
can successfully be used to enhance adhesion of HUVECs on the EShell polymer.   
   Proliferation of HUVECs was assessed on day 7. Compared to day 1 average 
cell count per cm2 of 226 +/- 55 (n=5), day 7 average cell counts increased to 48493  
+/- 1442 cells per cm2 (n=3). This difference is statistically significant with a confidence level of 
95%, using a 2 sample T-test (p = 0.042), thus indicating proliferation of the HUVECs has 
occurred over the 7 day study (Figure 21).   
  
Figure 21: Proliferation of HUVECs from day 1 to day 7. * indicates p < 0.05.  
Dynamic Growth Chamber Endothelial Cell Analysis  
  The purpose of the dynamic growth chamber experiments was to provide a 




beginning the more complex TPS bioreactor setup. For the dynamic growth chamber 
study, attachment efficiency was calculated after a 24 hour cell seeding period in static 
conditions. The average attachment efficiency was 16 % +/- 7, which is similar to that 
of the static condition study average attachment efficiency, which is expected since 
both were calculated after static conditions. The 24 hour seeding period in this study 
was considered to be day 0 of the study. Day 1 time point in the dynamic growth 
chamber study was after 24 hours under flow. When comparing Day 1 (24h) time 
point data of average cell count per cm2 between the static study (n=5 samples) and 
the dynamic study (n=4 samples) after 24 hours of flow, the dynamic study had a 
statistically significantly large average cell count per area than the static group (p = 
0.046) (Figure 22).   
  
Figure 22: Static versus dynamic, no pattern group HUVEC cell density on day 





This data suggests that the dynamic flow conditions may enhance or promote 
cell proliferation. However, when comparing the aspect ratio of these same two groups, 
there was no statistical difference between them (p=0.927), with both groups having an 
average aspect ratio near 1, meaning the majority of the cells were rounded. On the no 
pattern flat surface 2D scaffolds under dynamic flow, no orientation to the direction of 




    
Figure 23: Random orientation under flow, no pattern flat surface group. 10x.  
  
The original design dimensions of our topographical pattern, specifically the 
channels, was on the 100 to 150 micron scale, where this height would have fit the 
growth chamber apparatus. However, due to resolution limitations of the printer, the 




due to the gasket and larger channel size, there was a leak, likely due to the height of 
the channel pattern that prevented the vacuum from creating a complete seal around the 
print and gasket.  So, alternatively, we moved forward to perform dynamic flow effect 
analysis in the TPS bioreactor model.   
In Vitro Bioreactor Endothelial Cell Analysis  
  The purpose of the bioreactor study was to assess the effect of architecture and shear 
stress on endothelial cell monolayer formation. The experimental groups assessed in the 
bioreactor study are shown below in Figure 24. The experimental groups consisted on an 
overarching dynamic group with corresponding static controls. There was a static control for 
each specific dynamic experimental group. Within the dynamic group, three different 
diameters were tested: 4.5 mm, 10 mm, 16 mm inner diameters. At a constant flow rate, the 
shear stress decreases with increasing scaffold diameter (Figure 24). Within each diameter 
group, additionally 3 different surface topographies were tested – no pattern flat surface, 





Figure 24. Experimental groups assessed in the TPS bioreactor study.   
Although we were optimistic, due to the radius of the curvature we were unable to 
image through the scaffold and the surface of the scaffold for day 7 live/dead analysis. Out  
of all the experimental groups we attempted to image, we were able to pick up several 
images from the group 1 diameter scaffolds, the group with the smallest radius of 
curvature, shown in Figures 25 and 26. While the images obtained were too out of focus 
to perform morphology and orientation analysis, the majority of the cells visualized in 
the channels only group seemed to be aggregated to the area of the channels (Figure 
25). Additionally in the channels and pits scaffolds (Figure 26), the cells appeared to be 
aggregated. The dotted white line overlays in Figures 25 and 26 indicate where the 




   
Figure 25: Group 1 diameter, channels pattern at day 7 time point. 2.5x  
  
Figure 26: Group 1 diameter, channels and pits pattern at day 7 time point. 2.5x.  
DNA analysis was performed via a PICO green assay. Samples included all TPS 




group. The analysis of DNA in the samples are shown in Figure 27. Statistical 
significance was determined using one way ANOVA with a 95% confidence interval.  
  
Figure 27: DNA PICO green assay results showing all groups. The blue symbols 
indicate the dynamic groups and static groups with statistically significant 
differences in DNA levels. D = dynamic study experimental group. S = static 
study experimental group.  
Overall, all dynamic TPS bioreactor samples had higher levels of quantified 
DNA than the static controls. Additionally, when a scaffold in a specific experimental 
group from the TPS bioreactor was compared to its corresponding scaffold in the 
static control, there were statistically significant differences (p<0.05) in the following 
experimental groups: Group 1 channels, Group 2 channels and pits, Group 3 channels, 
and Group 3 channels and pits. In all of these groups, the dynamic TPS bioreactor 
sample had a statistically significant larger amount of DNA than its static counterpart.   
We can first focus on the effect of diameter on the DNA levels by keeping surface 




significance among the no patterned dynamic scaffolds with varying diameters, when 
comparing channel topography in a dynamics groups we found that there was statistically 
higher DNA levels in the smallest diameter scaffolds than the 10 mm inner diameter 
scaffolds (Figure 28). Additionally, when comparing channels and pits combination 
surface topography among the different diameter scaffolds, the 10 mm scaffold had a 
statistically higher level of DNA than the smallest diameter scaffold, by a factor of 
almost 9 fold (Figure 29). This difference is indicated by the star in Figure 29. 
Additionally when comparing the 10 mm diameter group to the largest diameter group, 
the 10 mm group also had a statistically higher DNA level by a factor of 3 fold (Figure 
29).   
  
Figure 28. DNA analysis of dynamic channels pattern scaffold among varying 







Figure 29. DNA analysis of dynamic channels pattern scaffold among varying 
diameter groups. Star and triangle represent statistically significant differences 
(P < 0.05).  
  Now keeping diameter constant we look at the effect of surface topography on 
DNA levels. In figure 30, we see that the channels topography had a statistically 
higher level of DNA than either the no pattern (as indicated by the star) and channels 
and pits combination pattern (indicated by the triangle) when looking at the results of 
the smallest diameter group of 4.5 mm (Figure 30). In the group with the 10 mm 
diameter, we see that the channels and pits topography had a statistically higher level 
of NDA than either the no pattern and channels combination group, as indicated by the 
star on the graph in Figure 31. In the group with the largest diameter, we see that both 




topography had a statistically higher level of DNA than the no pattern group (Figure 32), 
as indicated by the star and triangle symbols respectively.   
  
Figure 30. DNA analysis of group 1 diameter. Star and triangle indicate 





Figure 31. DNA analysis of group 2 diameter. Star indicate statistically different 
levels of DNA (P < 0.05).  
  
Figure 32. DNA analysis of group 3 diameter. Star and triangle indicate 
statistically different levels of DNA (P < 0.05).  
  
Discussion   
SolidWorks CFD Analysis   
  CFD analysis of the SolidWorks designs demonstrated varying flow profiles 
and velocities between different experimental groups. These velocities were on par 
with those shown to increase differentiation due to application of shear stress in 
previous TPS experiments. It was hypothesized that the variation in surface 
topography and diameter size would alter flow profiles and thus shear stress. The CFD 




groups is not very large. Future endeavors include doing additional simulations in a 
broader range of flow simulations higher than 20 mL/minute, which was the highest 
flow rate that was assessed in this study.   
Static Conditions Endothelial Cell Analysis   
HUVEC average attachment efficiency was also calculated on day 1 using 
live/dead imaging, which was found to be 23% +/- 6 (n=5). This is consistent with 
prior studies that have found fibronectin coating prior to seeding to enhance 
endothelial cell adhesion up to 20-30%. Proliferation of HUVECs was assessed on day 
7. Compared to day 1 average cell count per cm2 of 226 +/- 55 (n=5), day 7 average 
cell counts increased to 48493 +/- 1442 cells per cm2 (n=3).   
In the static conditions study, cells at the day 1 time point were consistently 
more rounded with an aspect ratio closer to 1 compared to cells at day 3 or day 7 
under the same conditions, and had an aspect ratio much greater than 1. The greater 
aspect ratio with increased time progression, indicates that the HUVECs are becoming 
more elongated, which is consistent with prior studies.35   
Dynamic Growth Chamber Analysis   
When comparing dynamic growth chamber samples at the Day 1 (24h) time 
point to static condition samples at the same time point, the dynamic study had a 
statistically significantly large average cell count per area than the static group (p = 
0.046) (Figure 22). These results suggest that dynamic flow conditions may enhance 




stress enhances proliferation.36 There are several potential factors that may be playing a 
role in this increased proliferation- flow conditions allow for enhanced nutrient 
transport, waste removal, and the shear stress on the surface of the endothelial cells 
may activate mechanosensors that could induce downstream signaling and ultimately 
gene expression within the endothelial cells.39 On the no pattern flat surface 2D 
scaffolds under dynamic flow, no orientation to the direction of flow was seen, which 
is consistent with prior research studies as well.35,37   
Future endeavors include producing a 2D patterned surface with a pattern small 
enough (on the order of a hundred microns or less) to fit the growth chamber model 
without leaks. This would allow us to analyze the effects of varying topography on the 
orientation of endothelial cells more clearly. Potential strategies at achieving this is by 
inverting the channel pattern so that the channels are printed into the surface, rather 
than as raised channels. Additionally, a longer term dynamic flow study beyond 24h 
would be beneficial in understanding the long term effects of flow and thus shear 
stress in combination with topographical patterns on endothelial monolayer formation.   
TPS Bioreactor Analysis   
Over early time points, the bioreactor culture was shown to support the 
proliferation of the cells. Bioreactor culture was shown that it may enhance 
proliferation, which is consistent with the increased DNA levels that were found in all 
dynamic culture samples compared to the corresponding static culture sample.   
 There were minimal differences seen among different topographical pattern scaffolds 




consistent with prior studies that have shown that nanotopography has little effect on 
cell morphology and proliferation in static conditions.35, 36  Of the images we were 
able to capture on day 7 during live/dead analysis, the majority of the cells visualized 
in the channels only group seemed to be aggregated to the area of the channels 
(Figure 25), which is consistent with previous studies. Additionally in the channels 
and pits scaffolds (Figure 26), the cells appeared to be aggregated in the pits, which 
has been previously been shown to reduce migration and enhance proliferation.34, 35    
In our initial study, we chose 20 ml/min as our flow rate to achieve a 
physiologically relevant surface shear stresses on the 3D printed scaffolds in the TPS 
bioreactor. Unfortunately we observed that the majority of cells that remained 
attached were in the pits (meant to provide cells a place to adhere and proliferate). We 
believe this may be due to the delamination of the fibronectin coating in other areas of 
the scaffold. Therefore, with these results, an additional studies are needed to 
investigate a bioreactor study using an order of magnitude lower flow rate (2 mL/min) 
to avoid this potential problem.  
  Overall, all dynamic TPS bioreactor samples had higher levels of quantified 
DNA than the static controls. Additionally, when a scaffold in a specific experimental 
group from the TPS bioreactor was compared to its corresponding scaffold in the 
static control, the TPS bioreactor scaffold had a higher quantity of DNA present, 
which indicates more cells present, and thus suggests enhanced proliferation. Our 
novel combination of channels and pits combination pattern showed the highest DNA 




27). In all diameter groups in the dynamic study, the topographical pattern scaffolds, 
either the channels, channels and pits combination, or both, had higher DNA levels 
than the dynamic scaffold with no pattern in the same diameter group; In the group 1 
diameter group, D2 was statistically greater than D1, in group 2 D6 was statistically 
greater than D4, and in group 3 both D8 and D9 were statistically greater than D7 
(Figure 27). These statistically higher DNA readings suggest that specific architectural 
combinations, such as diameter and surface topography in this study  
may have the ability to significantly enhance cell proliferation, and potentially 
monolayer formation as well. Specifically, novel pattern combinations, rather than 
testing single surface topographies alone may potentially provide more impactful 
contact guidance cues and signals to cells to dramatically increase cell proliferation and 
monolayer formation.   
  
Conclusion   
With over 185,000 limb amputations in the United States alone,2 and 
approximately 15 million bone fractures worldwide every year,1 there is a large 
clinical need for bone tissue engineering alternatives. At present, approximately 1 
million grafting procedures are performed each year. While current grafting 
procedures and surgical techniques help to heal bone defects, they also result in many 
undesirable effects including infection, graft rejection, donor site morbidity, and 
extended healing times. Recently, great strides have been made in the field of bone 




lack of inherent vasculature, which thus limits nutrient transfer. In order to increase the 
feasibility of cell based tissue engineering strategies, this limitation must be overcome.   
The most common component of engineered vascular constructs is the presence 
of endothelial cells. Many techniques are currently being investigated for the 
development of vascularized networks with the ultimate goal of developing inherent 
vasculature within engineered bone tissue grafts. Some of these methods include in 
vivo and in vitro prevascularization of grafts. Due to several disadvantages of the 
former methods mentioned, more recent research has focused on 3D printing of 
vascular scaffolds. Additionally, a common method for overcoming this nutrient 
transfer limitation is the use of bioreactor systems. An important benefit of bioreactor 
systems is their ability to create an in vitro environment that mimics the in vivo 
environment of the human body more closely.   
This research provides a promising and novel approach to the vascularization 
of bone tissue engineered constructs. Here, DLP stereolithographic printing is 
combined with in silico modeling and in vitro testing to design and validate 
biomimetic vascular architecture for use in TPS bioreactors. Under this system, cells 
can experience dynamic flow and accompanying shear stress to preferentially enhance 
endothelial cell layer formation.   
The first goal of this study was to determine what flow rate was to be used for 
producing a physiologically relevant shear stress in our TPS bioreactor study. This 
was accomplished by running computational fluid dynamic simulations at six different 




these simulations we determined that a flow rate of 20 mL/min would provide the 
shear stress that was closest to physiologically relevant levels than any of the other 
flow rates.   
Finally, in silico modeling results from SolidWorks were examined in vitro by 
running a 7 day bioreactor experiment with human umbilical vein endothelial cells in 
9 different experimental groups, as well as corresponding static controls for each 
group. In short, Day 7 DNA quantification results were statistically significant when 
comparing four of the bioreactor experimental groups to their corresponding static 
groups. Overall the DNA levels were higher in all dynamic groups compared to their 
static counterpart. Additionally in every diameter group in the dynamic portion of the 
study, one or both of the topographical scaffolds always had a statistically higher level 
of DNA than the no pattern scaffold in the same diameter group. Of note, the Group 2 
diameter with channels and pore topographical pattern had a statistically significantly 
higher level of DNA, and thus cell proliferation than any other experimental group, 
suggesting the potential ability of novel topographical pattern and diameter 
combinations to significantly enhance cell proliferation and eventually endothelial cell 
monolayer formation.   
The vascular network designed and printed here shows promise not only for 
use in TPS bioreactors, but also many other dynamic culture strategies. By combining 
this architecture with a biodegradable network material and a lining of endothelial 
cells, it may be possible to create a vascular network that provides for the extended 




grafts. Further, the incorporation of large-diameter inlet and outlet channels allows for 
the potential direct anastomosis of these constructs to existing host vasculature.  
Ideally, this inherent graft vasculature would sustain cell life until the network can be fully 
integrated with the body via spontaneous host vascular ingrowth.  
Through the studies we presented here we have presented a proof of concept of 
fibronectin as a successful substrate for HUVECs on EShell polymer surfaces. 
Additionally, we have shown proof of concept of successfully printed a novel 
combination of channels and pits topography and illustrated that these topographical 
combinations do alter shear stress, as visualized on the SolidWorks flow simulations. 
Furthermore, we demonstrated that changes in shear stress due to this varying 
architecture has the potential to influence cell behavior and proliferation. From the 
studies presented here, we were able to investigate the short term effects of shear 
stress and architecture on endothelial cell behavior; with this information, it would 
now be useful to look at longer term effects of these factors on endothelial cell 
behavior.  
In summary, a thorough combination of computer-aided design, in silico 
modeling, and in vitro experiments resulted in the development of a 3D printed with 
novel architecture has been utilized to illustrate the potential of surface topography 
and shear stress to enhance endothelial cell monolayer formation. While no complete 
monolayer formation was visualized, these initial results are encouraging, but 




performed to determine and solidify which architectural combination results in an 
endothelial cell monolayer formation.   
  
Chapter 4: Appendix A: Raw Data & Calculations   
Static Condition Studies   
In all of the cell count data below, cell counts from images were converted to cell 
counts on the prints using the following conversions and calculations:   
Image sizes on Image J:   
2.5x mag: 319 pixels = 1000 microns  
10x mag:1069 pixels = 1000 microns  
20x mag: 1499 pixels = 700 microns  
40x mag = 1486 pixels = 350 microns  
Multiply cell count from images by ratio of: area of print / area of image  
Day 1 (24h)  
  
10x 
images   
Image  
1   
Image  
2   
Image  
3   
Image  
4   
Image  
5   
Average  
Cell  
Count/ cm2  
Sample 1   371  480  393  401  436  249  
Sample 2  551  338  313  319  332  221  




Sample 5  37  1  47  9  23  124  
Sample 6  6  8  7  1  2  286  
Average            226 +/- 55  
Table 4: No pattern/flat surface cell counts and calculations at day 1 time point.  
  
Sample  Seeding  
Density  
Cells/ cm2  
Number of  
cells seeded   
Total Cells 
counted print  
Attachment  
Efficiency (%)   
1    5000  234000  59953  25  
2  5000  234000  53384  23  
3  5000  234000  59838  26  
4  5000  25000  3001  12  
5  5000  25000  6914  28  
Average        23 +/- 6  
Table 5: No pattern/flat surface attachment efficiency data at Day 1 time point.  
  
Side 1 Side 2 Aspect Ratio 
138  57  2.421053  
133  85  1.564706  
143  35  4.085714  
133  25  5.32  
47  25  1.88  
60  60  1  
361  94  3.840426  
96  48  2  
150  82  1.829268  
177  68  2.602941  




Side 1 Side 2 Aspect Ratio 
196  47  4.170213  
111  54  2.055556  
106  44  2.409091  
88  17  5.176471  
190  72  2.638889  
95  20  4.75  
160  58  2.758621  
215  86  2.5  
109  34  3.205882  
Table 6: Aspect ratio data and calculations at day 1 time point.  





Image 2  Image 3  Image 4  Image 5  Total Cells  
Counted in 
print  
Sample 1  17  36  27  17  28  36013  
Sample 2  18  14  10  17  14  1873  
Sample 3  17  10  8  18  13  1693  
Sample 4  3  7  20  4  22  1436  
Average            10254  
Table 7: No pattern flat surface cell count data at day 3 time point.  
  
Side 1  Side 2 Aspect Ratio 
213  73  2.917808  
278  24  11.58333  
152  46  3.304348  
271  20  13.55  
270  48  5.625  
460  48  9.583333  
328  45  7.288889  
353  29  12.17241  
429  27  15.88889  
85  42  2.02381  
443  40  11.075  
160  77  2.077922  




Side 1  Side 2 Aspect Ratio 
280  49  5.714286  
212  43  4.930233  
203  21  9.666667  
350  27  12.96296  
159  44  3.613636  
308  66  4.666667  
247  42  5.880952  
169  17  9.941176  
181  14  12.92857  
267  54  4.944444  
140  46  3.043478  
288  36  8  
338  56  6.035714  
354  26  13.61538  
409  49  8.346939  
Table 8: Aspect ratio data at day 3 time point.  
Day 7:  Proliferation  
10x 
images   
Image  
1 Cell  
Count  




3 Cell  
Count   
Image  
4 Cell  
Count   
Image 5  
Cell  
Count   
Average # 
cells per 








5   
298  0  0  486  368  231  2417829  68572  
Sample 
7  
0  0  308  170  220  140  1464969  41548  
Sample  
8   
650  450  350  250  500  440  1255210  35358  
Average          48493  
 +/- 1442  
  





Dynamic Growth Chamber Studies   
Day 1 
(10x   
Image  
1 Cell  
Count  
Image  
2 Cell  
Count  
Image  
3 Cell  
Count   
Image  
4 Cell  
Count   
Image  
5 Cell  










cm2   
Sample 1  14  12  12  13  13  13  64  12765  
Sample 2  1  2  1  1  1  1  6  1197  
Sample 3  38  35  35  35  31  35  174  10287  
Sample 4  37  35  36  35  30  35  173  10228  
Average                8620 +/-  
4406  
Table 10: No pattern/flat surface total cells on 2D prints at day 1 time point.  
  
Sample  Seeding  
Density  
Cells/ cm2  
Number of  
cells seeded   
Total Cells 
counted print  
Attachment  
Efficiency (%)   
1  5000  177000  16134  9  
2  5000  177000  36013  15  
3  5000  25000  3001  12  
4  5000  25000  6914  28  
Average        16 +/- 7  
Table 11: No pattern flat surface, attachment efficiency at day 1 time point.   
  
Side 1  Side 2   AR  
143  72  1.986111  
38  33  1.151515  
32  31  1.032258  
10  10  1  




Bioreactor Study  
Pre-TPS bioreactor study setup calculations   






1   11.1252  6.35  2.3876  
2   19.05  12.7  3.175  
3  25.4  19.05  3.175  
Table 13: Tubing sizes available for TPS bioreactor study.  
  








1   5.5  4.5  1  62  
2   11  10  1  25.5  
3   17  16  1  16.5  
Table 14: Diameters of 3D scaffolds based on tubing sizes.  
  
Tubing type  
# of tubing 
segments 
needed  
# of lines  
Total # of 
segments 
needed  
Length of each segment (2 
scaffolds + connectors at 
each end) (mm)  
Length of 
each segment  
(in)  
1/4”  2  2  4  151  6  
1/2”  2  2  4  102  4.1  
3/4”  2  2  4  90  3.5  
Connector 
type  
# needed per 
line  





1/81/4  2  2  4  
1/41/2  2  2  4  
1/23/4  2  2  4  
3/43/4  1  2  2  






type   
Length  each 





Total SA of 
each (in^2)  
1/4”  6  4.7  4  18.8  
1/2”  4.1  6.5  4  25.8  
3/4"  3.5  8.3  4  32.3  
Total SA        77 in^2  
        497 cm^2  
Table 16: Total inner surface area of scaffolds in bioreactor setup.   
  
Based on SA to media ratio of T-75 (75 cm^2: 12 mL media):   
    Total amount of media needed for tubing: 80 mL    
    Amount of media needed for each separate line: 40 mL   
    Amount of media to be added to each media reservoir flask: 100 mL  
Tubing 
type   
Length  each 





Total V of 
each (in^3)  
1/4”  6  0.30  4  1.20  
1/2”  4.1  0.81  4  3.22  
3/4"  3.5  1.55  4  6.20  
Total 
Volume  
      10.62 in^3  
        174 cm^3 =  
174 mL  
Table 17: Total volume of tubing in TPS bioreactor.  
 
Tubing 
type   
Length  each 
segment (in)  
Inner SA 
(in^2)  




Total SA of 
each (in^2)  
1/4”  6  4.7  30.4  4  121.4  
1/2”  4.1  6.5  42.0  4  168.0  
3/4"  3.5  8.3  53.6  4  214.4  
Total SA           78 in^2  




Table 18: Total HUVEC requirement needed based on total inner surface area 
of scaffolds in bioreactor setup.   
Cell seeding density: 5,000 cells/ cm2   
Total amount of cells required:  504* 5,000 = million cells   
DNA Analysis: Data and Calculations  
High    
0.000875  -0.00497  
5.2E-06  0.002683  
0.999894  0.005186  
28377.19  3  
0.763156  8.07E-05  
#N/A  #N/A  






Table 20: PICO green plate setup. H= high standard curve, L = low standard 
curve. D = dynamic conditions sample (TPS bioreactor). S = static conditions 
sample. Sample 1 = group 1, no pattern. Sample 2 = group 1, channels. Sample 3 
= group 1, channels and pits. Sample 4 = group 2, no pattern. Sample 5 = group  
2, channels. Sample 6 = group 2, channels and pits. Sample 7 = group 3, no 
pattern. Sample 8 = group 3, channels. Sample 9 = group 3, channels and pits.   
 Table 20: PICO green plate setup. H= high standard curve, L = low standard 
curve. D = dynamic conditions sample (TPS bioreactor). S = static conditions 
sample. Sample 1 = group 1, no pattern. Sample 2 = group 1, channels. Sample 3 
= group 1, channels and pits. Sample 4 = group 2, no pattern. Sample 5 = group  
2, channels. Sample 6 = group 2, channels and pits. Sample 7 = group 3, no 
pattern. Sample 8 = group 3, channels. Sample 9 = group 3, channels and pits.   
 
  1  2  3  4  5  6  7  8  9  10  11  






























F      1.84E-05  8.25E-06  3.05E-05  2.98E-05  2.54E-05  2.02E-05        
G      0.000176  0.000152  0.000189  3.24E-05  2.02E-05  4.23E-05        
H      0.000852  0.00088  0.000941  2.45E-05  2.18E-05  2.16E-05        









  1  2  3  4  5  6  7  8  9  10  11  






























F      1.84E-05  8.25E-06  3.05E-05  2.98E-05  2.54E-05  2.02E-05        
G      0.000176  0.000152  0.000189  3.24E-05  2.02E-05  4.23E-05        
H      0.000852  0.00088  0.000941  2.45E-05  2.18E-05  2.16E-05        
Table 22: PICO green plate results in micrograms/mL and corresponding to 
plate setup above.   
  
  
Label  Ones Different Than (p<0.05)  
D1  D6, D4, D2  
D2  D6, D9, D1, S1, D5, D3, D7, S9, S6, S7, S5, S4, S8,  
S2  
D3  D6, D2, D8, D9  
D4  D6  
D5  D6, D2  
D6  All  
D7  D6. D2. D8. D9.   
D8  D6, S1, D3, D7,S9,S6,S7,S5,S4,S8,S2  
D9  D6, D2,S1,D3, D7,S9,S6,S7,S5,S4,S8,S2  
S1  D6,D2,D8,D9,S9,S6,S7,S5,S4,S8,S2  
S2  D6,D2,D8,D9,S1  
S4  D6,D2,D8,D9,S1  




Label  Ones Different Than (p<0.05)  
S6  D6,D2,D8,D9,S1  
S7  D6,D2,D8,D9,S1  
S8  D6,D2,D8,D9,S1  
S9  D6,D2,D8,D9,S1  
Table 23: PICO green results. a. Average and standard deviation values for each 


























Chapter 5:  Appendix B: SolidWorks CFD Results    
    
Shear Stress Surface Plot Contours   
  
Figure 33: Group 1 no pattern at 0.5 mL/minute flow rate.  
  
Figure 34: Group 1 no pattern at 1 mL/minute flow rate.  
  





Figure 36: Group 1 no pattern at 5 mL/minute flow rate.  
  
Figure 37: Group 1 no pattern at 10 mL/minute flow rate.  
  





Figure 39: Group 1 with channels at 0.5 mL/minute flow rate.  
  
Figure 40: Group 1 with channels at 1 mL/minute flow rate.  
  
Figure 41: Group 1 with channels at 2 mL/minute flow rate.  
          
     
  





Figure 42: Group 1 with channels at 5 mL/minute flow rate.  
  
Figure 43: Group 1 with channels at 10 mL/minute flow rate.  
  
Figure 44: Group 1 with channels at 20 mL/minute flow rate.  
  






Figure 46: Group 1 with channels and pits at 1 mL/minute flow rate.  
  
Figure 47: Group 1 with channels and pits at 2 mL/minute flow rate.  
  





Figure 49: Group 1 with channels and pits at 10 mL/minute flow rate.  
  
Figure 50: Group 1 with channels and pits at 20 mL/minute flow rate.  
  
  
Figure 51: Group 2 no pattern at 0.5 mL/minute flow rate.  
  





Figure 53: Group 2 no pattern at 2 mL/minute flow rate.  
  
Figure 54: Group 2 no pattern at 5 mL/minute flow rate.  
  
Figure 55: Group 2 no pattern at 10 mL/minute flow rate.  
  






Figure 57: Group 2 with channels at 0.5 mL/minute flow rate.  
  
Figure 58: Group 2 with channels at 1 mL/minute flow rate.  
  





Figure 60: Group 2 with channels at 5 mL/minute flow rate.  
  
Figure 61: Group 2 with channels at 10 mL/minute flow rate.  
  






Figure 63: Group 2 with channels and pits at 0.5 mL/minute flow rate.  
  
Figure 64: Group 2 with channels and pits at 1 mL/minute flow rate.  
  





Figure 66: Group 2 with channels and pits at 5 mL/minute flow rate.  
  
Figure 67: Group 2 with channels and pits at 10 mL/minute flow rate.  
  






Figure 69: Group 3 no pattern at 0.5 mL/minute flow rate.  
  
Figure 70: Group 3 no pattern at 1 mL/minute flow rate.  
  





Figure 72: Group 3 no pattern at 5 mL/minute flow rate.   
  





Figure 74: Group 3 no pattern at 20 mL/minute flow rate.  
  
  





Figure 76: Group 3 with channels at 1 mL/minute flow rate.  
  
Figure 77: Group 3 with channels at 2 mL/minute flow rate.  
  





Figure 79: Group 3 with channels at 10 mL/minute flow rate.  
  
Figure 80: Group 3 with channels at 20 mL/minute flow rate.  
  





Figure 82: Group 3 with channels and pits at 1 mL/minute flow rate.  
  
Figure 83: Group 3 with channels and pits at 2 mL/minute flow rate.  
  





 Figure 85: Group 3 with channels and pits at 10 mL/minute flow rate.  
  







Flow Trajectories  
  
Figure 87: Group 1 no pattern at 0.5 mL/minute flow rate.  
  
Figure 88: Group 1 no pattern at 1 mL/minute flow rate.  
  





Figure 90: Group 1 no pattern at 5 mL/minute flow rate.  
  
Figure 91: Group 1 no pattern at 10 mL/minute flow rate.  
  





Figure 93: Group 1 with channels at 0.5 mL/minute flow rate.  
  
Figure 94: Group 1 with channels at 1 mL/minute flow rate.  
  





Figure 96: Group 1 with channels at 5 mL/minute flow rate.  
  
Figure 97: Group 1 with channels at 10 mL/minute flow rate.  
      





Figure 99: Group 1 with channels and pits at 0.5 mL/minute flow rate.  
  
Figure 100: Group 1 with channels and pits at 1 mL/minute flow rate.  
  





Figure 102: Group 1 with channels and pits at 5 mL/minute flow rate.  
  
Figure 103: Group 1 with channels and pits at 10 mL/minute flow rate.  
  





Figure 105: Group 2 no pattern at 0.5 mL/minute flow rate.  
  
Figure 106: Group 2 no pattern at 1 mL/minute flow rate.  
  





Figure 108: Group 2 no pattern at 5 mL/minute flow rate.  
  
Figure 109: Group 2 no pattern at 10 mL/minute flow rate.  
  





Figure 111: Group 2 with channels at 0.5 mL/minute flow rate.  
  





Figure 113: Group 2 with channels at 2 mL/minute flow rate.  
  
Figure 114: Group 2 with channels at 5 mL/minute flow rate.  
  





Figure 116: Group 2 with channels at 20 mL/minute flow rate.  
  





Figure 118: Group 2 with channels and pits at 1 mL/minute flow rate.  
  





Figure 120: Group 2 with channels and pits at 5 mL/minute flow rate.  
  
Figure 121: Group 2 with channels and pits at 10 mL/minute flow rate.  
  






Figure 123: Group 3 no pattern at 0.5 mL/minute flow rate.  
  





Figure 125: Group 3 no pattern at 2 mL/minute flow rate.  
   
Figure 126: Group 3 no pattern at 5 mL/minute flow rate.   
  





Figure 128: Group 3 no pattern at 20 mL/minute flow rate.  
  
Figure 129: Group 3 with channels at 0.5 mL/minute flow rate.  
  





Figure 131: Group 3 with channels at 2 mL/minute flow rate.  
  





Figure 133: Group 3 with channels at 10 mL/minute flow rate.  
  





Figure 135: Group 3 with channels and pits at 0.5 mL/minute flow rate.  
  





Figure 137: Group 3 with channels and pits at 2 mL/minute flow rate.  
  





Figure 139: Group 3 with channels and pits at 10 mL/minute flow rate.  
  
Figure 140: Group 3 with channels and pits at 20 mL/minute flow rate.  
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